Topical Management of arterial and venous ulcers - VascularWeb

More documents

Recommendations

Info

Vulcan: results• No difference in 12 weeks healing rates• No difference in QOL assessments• Did not report incidence of wound infection• Cost-efficacy better for non-silvercontaining dressings
What to put on the wound?• Over 5000 dressing products available forcovering wounds• Tremendous lack of comprehensiveresearch on most• Minimal regulatory requirements forapproval of dressing products• Key concept is moist wound healing andmanagement of wound exudate
Page 1 and 2: Professor of Surgery Chief, Divisio
Page 3 and 4: DisclosuresScientific Consultant•
Page 6 and 7: Venous/lymphatic ulcer• Common as
Page 8 and 9: • May be inatypicallocations• T
Page 10: Causes of Atypical WoundsInfectious
Page 13 and 14: When to biopsy a• Long durationch
Page 15 and 16: Rx protocol for VLU• Compression
Page 17 and 18: Coexistent arterial insufficiency:H
Page 19 and 20: Topical therapy• Wound debridemen
Page 21 and 22: Special considerations forpatients
Page 23 and 24: How much to debride?
Page 25 and 26: The necrotic toe
Page 27 and 28: Wound bacterial load• Bacterial c
Page 29 and 30: Biofilm/bacterial burden
Page 31 and 32: Wound bacteria data - chronicVLU•
Page 33: Vulcan trial• Michaels et al Br J
Page 37 and 38: Demonstrated effects of chronicwoun
Page 39 and 40: Exudate Management:DressingsNone Lo
Page 41 and 42: Hydrocolloids• Provide barrier if
Page 43 and 44: Foams, Specialty absorbents• High
Page 45 and 46: Negative pressure compared tomoist

Topical Management of arterial and venous ulcers - VascularWeb

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?